MD Medical Group is Russia's Undisputed Leader in Assisted Reproductive Technology

MD Medical Group IPJSC (“MD Medical”, “MDMG”, "Group" or the "Company"; MOEX: MDMG), a leading Russian private healthcare provider, has reaffirmed its superiority in the field of in vitro fertilisation (IVF) in the private sector, posting a significant achievement in Russia’s national register of records.

Today, on the World IVF Day, the national register of records marks a significant milestone of the highest number of embryo transfers in a single year: in 2023, MDMG clinics and hospitals achieved a remarkable 21,435 embryo transfers. As a result of successful IVF by MDMG fertility specialists, about 6,500 babies have already been born in 2023–2024 or expected to arrive over the next few months.

MDMG clinics have been performing IVF treatments since the Company’s inception in 2006. Moreover, our Group boasts a rich history of pioneering IVF care, with some of our medical centres initiating treatments even earlier. The IDK hospital in Samara stands out as a champion here, making Samara the third city in Russia where IVF technology was successfully implemented and resulted in the birth of a test-tube baby in 1992.

MD Medical Group is currently an undisputed leader in assisted reproductive technology, accounting for over 18% of all IVF oocyte retrievals in Russia. Our IVF success rates are truly exceptional, with more than 45% of cases resulting in a long-awaited pregnancy.

About MD Medical

MD Medical is a leading provider in the highly attractive Russian private healthcare service market. Today, the Company manages 56 state-of-the-art healthcare facilities, including 11 multidisciplinary hospitals and 45 out-patient clinics in 28 regions of the Russian Federation. In 2023, MD Medical's revenue amounted to RUB 27.6 bln while EBITDA was RUB 9.2 bln.